Citation
Kantor ED, Onstad L, Blount PL, Reid BJ, Vaughan TL. Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2012 Mar;21(3):456-61 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22241250.
Critical appraisals
Compare quality appraisals for each clinical question
- Are there any treatments that prevent progression of BO to cancer? (compare critical appraisals)
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma? (compare critical appraisals)
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance? (compare critical appraisals)
- Are there groups of patients with BO that can be discharged from surveillance? (compare critical appraisals)
Cited by
Social links